1 Easton JD, Saver JL, Albers GW, et al. Definitionand evaluat ion of t ransient ischemic at t ack:ascientific statement for healthcare professionalsfrom the American Heart Association/AmericanStroke Association Stroke Council; Council onCardiovascular Surgery and Anesthesia; Council onCardiovascular Radiology and Intervention; Councilon Cardiovascular Nursing; and the InterdisciplinaryCouncil on Per ipheral Vascular Disease. TheAmer ican Academy of Neurology aff i rms thevalue of this statement as an educational tool forneurologists[J]. Stroke, 2009, 40:2276-2293.2 Wu CM, McLaughlin K, Lorenzetti DL, et al. Earlyrisk of stroke after transient ischemic attack:asystematic review and meta-analysis[J]. Arch InternMed, 2007, 167:2417-2422.3 Giles MF, Roth Well PM. Risk of stroke early aftertransient ischaemic attack:a systematic review andmeta-analysis[J]. Lancet Neurol, 2007, 6:1063-1072.4 Sanders LM, Srikanth VK, Jolley DJ, et al. MonashTransient Ischemic Attack Triaging Treatment:safetyof a transient ischemic attack mechanism-basedoutpatient model of care[J]. Stroke, 2012, 43:2936-2941.5 Sacco RL, Kasner SE, Broderick JP, et al. An updateddefinition of stroke for the 21st century:a statementfor healthcare professionals from the American HeartAssociation/American Stroke Association[J]. Stroke,2013, 44:2064-2089.6 Warlow C, van Gijn J, Dennis M, et al. Is it avascular event and where is the lesion? Identifyinga n d i n t e r p r e t i n g t h e s ymp t oms a n d s i g n sof c e r ebrova scula r di se a se //St roke:Pr a c t ica lManagement[M]. 3rd ed. Oxford, UK:BlackwellPublishing Ltd, 2008:35-130.7 Ay H, Arsava EM, Johnston SC, et al. Clinical- andimaging-based prediction of stroke risk after transientischemic attack:the CIP model[J]. Stroke, 2009,40:181-186.8 Bra zzelli M, Chappell FM, Mi randa H, et al.Diffusion-weighted imaging and diagnosis of transientischemic attack[J]. Ann Neurol, 2014, 75:67-76.9 李俊玉, 毕齐. 关于短暂性脑缺血发作的最新认识[J].中国卒中杂志, 2012, 1:36-39.10 短暂性脑缺血发作中国专家共识组. 短暂性脑缺血发作的中国专家共识更新版(2011年)[J]. 中华危重症医学杂志(电子版), 2012, 2:100-105.11 Johnston SC, Nguyen-Huynh MN, Schwarz ME, etal. National Stroke Association Guidelines for themanagement of transient ischemic attacks[J]. AnnNeurol, 2006, 60:301-313.12 National Stroke Foundation; Boddice G, BrauerS, Gustafsson L. Clinical Guidelines for StrokeManagement 2010[M]. Melbourne:National StrokeFoundation, 2010:71-72.13 National Collaborating Centre for Chronic Conditions(UK). National clinical guideline for diagnosis andinitial management of acute stroke and transientischaemic attack (TIA)[J]. Stroke, 2008, 9891:501-515.14 Stroke Foundation of New Zealand and New ZealandGuidelines Group. New Zealand Clinical Guidelinesfor Stroke Management 2010[M]. Wellington:StrokeFoundation of New Zealand, 2010:99-113.15 Diener HC, Bogousslavsky J, Brass LM, et al. Aspirinand clopidogrel compared with clopidogrel alone afterrecent ischaemic stroke or transient ischaemic attackin high-risk patients (MATCH):randomised, doubleblind,placebo-controlled trial[J]. Lancet, 2004,364:331-337.16 SPS3 Study Group, Benavente OR, Coffey CS, et al.Blood-pressure targets in patients with recent lacunarstroke:the SPS3 randomised trial[J]. Lancet, 2013,382:507-515.17 Geeganage CM, Diener HC, Algra A, et al. Dualor mono antiplatelet therapy for patients with acuteischemic stroke or transient ischemic attack:systematicreview and meta-analysis of randomized controlledtrials[J]. Stroke, 2012, 43:1058-1066.18 Wang Y, Wang Y, Zhao X, et al. Clopidogrel withaspirin in acute minor stroke or transient ischemicattack[J]. N Engl J Med, 2013, 369:11-19.19 短暂性脑缺血发作中国专家共识组. 短暂性脑缺血发作与轻型卒中抗血小板治疗中国专家共识(2014年)[J].中华医学杂志, 2014, 94:2092-2096.20 Lansberg MG, O'Donnell MJ, Khat r i P, et al.Antithrombotic and thrombolytic therapy for ischemicstroke:Antithrombotic Therapy and Preventionof Thrombosis, 9th ed:American College of ChestPhysicians Evidence -Based Clinical Pr act iceGuidelines[J]. Chest, 2012, 141:601-636.21 Be sson G, Bogousslavsk y J. Eu rope an at r ialfibrillation trial (EAFT). Secondary prevention withanticoagulants and aspirin in patients with nonvalvularatrial fibrillation having suffered a transientischemic attack or a regressive vascular accident[J].Rev Med Suisse Romande, 1991, 111:49-55.22 Furie KL, Kasner SE, Adams RJ, et al. Guidelinesfor the prevention of stroke in patients with stroke ortransient ischemic attack:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J]. Stroke, 2011, 42:227-276.23 Kernan WN, Ovbiagele B, Black HR, et al. Guidelinesfor the prevention of stroke in patients with stroke andtransient ischemic attack:a guideline for healthcareprofessionals from the American Heart Association/Amer ican St roke Association[J]. St roke, 2014,45:2160-2236.24 Amarenco P, Goldstein LB, Szarek M, et al. Effects ofintense low-density lipoprotein cholesterol reductionin patients with stroke or transient ischemic attack:theStroke Prevention by Aggressive Reduction inCholesterol Levels (SPARCL) trial[J]. Stroke, 2007,38:3198-3204.25 Ginsberg HN. The 2013 ACC/AHA guidelines on thetreatment of blood cholesterol:Questions, questions,questions[J]. Circ Res, 2014, 5:761-764.26 王力, 张茁, 何晓芬. 541例复发缺血性脑卒中与短暂性脑缺血发作患者二级预防现状[J]. 中国神经精神疾病杂志, 2010, 10:594-597.27 Zaidat OO, Werz MA, Landis D, et al. Orthostaticl imb shak ing f rom ca rot id hy pope r f usion[J ].Neurology, 1999, 5:650-651.28 Fisher CM. Concerning recurrent transient cerebralischemic attacks[J]. Can Med Assoc J, 1962, 86:1091-1099.29 骆迪, 毕齐. 肢体抖动型短暂性脑缺血发作的研究进展[J]. 中国卒中杂志, 2012, 7:68-70.30 Janssen AW, de Leeuw FE, Janssen MC. Risk factorsfor ischemic stroke and transient ischemic attack inpatients under age 50[J]. J Thromb Thrombolysis,2011, 31:85-91.31 骆迪, 毕齐. 青年短暂性脑缺血发作患者危险因素及预后随访研究[J]. 中国卒中杂志, 2012, 7:17-22.32 Imaizumi T1, Hayashi K, Saito K, et al. Long-termoutcomes of pediatric moyamoya disease monitoredto adulthood[J]. Pediatr Neurol, 1998, 18:321-325.33 Research Committee on the Pathology and Treatmentof Spontaneous Occlusion of the Circle of Willis,Health Labour Sciences Research Grant for Researchon Measures for Infractable Diseases. Guidelinesfor diagnosis and treatment of moyamoya disease(spontaneous occlusion of the circle of Willis[J].Neurol Med Chir(Tokyo), 2012, 52:245-266. |